PRP from Personal Blood Relieves Joint Fluid-Inducing Synovial Injury through NF-κB Pathway and Mitochondrial Apoptosis in Human Synovial Fibroblast Cells

BACKGROUND: Platelet-rich plasma (PRP) therapy is a new kind of biological therapy to retune the plasma concentrator into the patient's body for the treatment of osteoarthritis diseases. The present research aimsed to confirm the treatment effects of PRP against osteoarthritis injury and elucidate its potential mechanism via constructing a kind of cellular injury model of human synovial fibroblast cells (HSF cells) induced by synovial fluid from osteoarthritis patients. MATERIALS AND METHODS: HSF cells wereas firstly treated with the different doses of synovial fluid from osteoarthritis patients, and evaluated for the cellular injury via cell morphology and MTT assay. And then, the protective effect of PRP against cellular injury were examined by cell morphology and MTT assay. Following, flow cytometry and western blot assay were employed to evaluate the effect of PRP on mitochondrial apoptosis. Finally, the effect of PRP on NF-κB pathway-associated inflammation wasere examined by Elisa ELISA assay and western blot. RESULTS: The dilution ratio 1 : 5 of synovial fluid displayed an excellent injury effect against HSF cells and selected as the model condition. The data from cellular image and MTT assay showed that PRP with the doses 1 : 5 and 1 : 10 could alleviate the cellular mounts decrease in the damaged HSF cells. Flow cytometry, western blot, and Elisa ELISA assay displayed that PRP could relieve the cellular mitochondrial apoptosis and NF-κB pathway-associated inflammation in the damaged HSF cells. CONCLUSION: PRP might relieve HSF cells injury induced by synovial fluid from osteoarthritis patients through alleviating the mitochondrial apoptosis and NF-κB pathway-associated inflammation.